| |
|
|
|
Kazia Therapeutics Ltd  
|
|
6.4 2.15 (0.51%) |
08-07 16:00 |
|
Open: |
7.6999 |
Pre close: |
4.25 |
Target:
|
9.50 
|
|
High: |
8.13 |
Low: |
5.83 |
Resistance:
|
8.13
9.50
|
|
Volume: |
21,175,416 |
Market Cap: |
44M |
Support:
|
5.11
3.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.48
|
MACD |
MACD(12,26):
|
0.33 |
|
MA(20): |
4.11 |
Signal(12,26,9): |
0.21 |
|
MA(100): |
3.20 |
Stochastic Oscillator |
%K(14,3):
|
48.57 |
|
MA(250): |
3.52 |
%D(3): |
40.73 |
|
Average Volume(K) |
3-Month: |
42452
|
52-Week |
High:
|
9.74 |
|
10-Days: |
216137 |
Low: |
2.27 |
|
RSI |
RSI(14):
|
83.72 |
Change(%): |
162.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-66.1 |
Shares Out. (M) |
7.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.9 |
Shares Float (M) |
4.01 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-18.6 |
% Held by Institutions |
3.56 |
|
Forward EPS |
-1.258 |
Gross Profit (p.s.) |
0.213 |
Shares Short (K) |
10 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.96 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
